Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.

NOX enzymes as novel targets for drug development

Open access
Lambeth, J. David, Krause, Karl-Heinz, Clark, Robert A. · 2008 · Seminars in Immunopathology

Abstract

The members of the NOX/DUOX family of NADPH oxidases mediate such physiologic functions as host defense, cell signaling, and thyroid hormone biosynthesis through the generation of reactive oxygen species (ROS), including superoxide anion and hydrogen peroxide. Moreover, ROS are involved in a broad range of fundamental biochemical and cellular processes, and data accumulated in recent years indicate that the NOX enzymes comprise one of the most important biological sources of ROS. Given the high biochemical reactivity of ROS, it is not surprising that they have been implicated in a wide variety of pathologies and diseases. Prominent among the settings that feature ROS-mediated tissue injury are disorders associated with inflammation, aging, and progressive degenerative changes in cells and organ systems, and it appears that essentially no organ system is exempt. Among the disorders currently believed to be mediated at least in part by NOX-derived ROS are hypertension, aortic aneurysm, myocardial infarction (and other ischemia-reperfusion disorders), pulmonary fibrosis and hypertension, amyotropic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ischemic stroke, diabetic nephropathy, and renal cell carcinoma. Several small-molecule and peptide inhibitors of the NOX enzymes have been useful in experimental studies, but issues of specificity, potency, and toxicity militate against any of the existing published compounds as candidates for drug development. Given the br…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00281-008-0123-6

Cites

308 of 308 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 307 references

Cited by

See all 212

Metadata

Authors
Lambeth, J. D., Krause, K.-H., & Clark, R. A.
Affiliations
  • Emory University (US)
  • University of Geneva (CH)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Lambeth, J. David
Venue
Seminars in Immunopathology
Published
2008-05-29
Volume
30
Issue
3
Pages
339-363
ISSN
  • 1863-2297 (ISSN-L)
  • 1863-2300
OpenAlex
W2031193867
Cited by
212
References
307
Citations by year
2026: 2 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 7 · 2017: 14 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 16 · 2012: 28
FWCI
1.64
Type
journal article
Language
en
Open access
Licence
Locations
  • Seminars in Immunopathology (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • National Cancer Institute (CA084138, R01CA084138, CA 105116)
  • National Institute of Allergy and Infectious Diseases (R01AI020866)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords
NADPH oxidase, reactive oxygen species, superoxide, hydrogen peroxide, NOX inhibitors, drug development, isoform specificity, oxidative stress, inflammation, aging, hypertension, ischemia-reperfusion injury, neurodegenerative diseases, pulmonary fibrosis, diabetic nephropathy, renal cell carcinoma, host defense, thyroid hormone synthesis
MeSH terms
Animals, Drug Evaluation, Enzyme Inhibitors, Humans, Reactive Oxygen Species, NADPH Oxidases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NOX enzymes as novel targets for drug development. https://app.cochat.ai/papers/10.1007/s00281-008-0123-6
The paper
Lambeth, J. D., Krause, K.-H., & Clark, R. A. (2008). NOX enzymes as novel targets for drug development. Seminars in Immunopathology. https://doi.org/10.1007/s00281-008-0123-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.